@ipimediaworld profile picture
IPI Journal @ipimediaworld

IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare.

Joined April 2016
  • Tweets 1,634
  • Following 64
  • Followers 123
416 Photos and videos
Canton of Geneva supports Connect in Pharma 2023 Geneva’s position as a leading European... tinyurl.com/2qz2x9xj tinyurl.com/2qz2x9xj

Canton of Geneva supports Connect in Pharma 2023 - International Pharmaceutical Industry

Geneva’s position as a leading European life science hub makes it the ideal choice for Connect in Pharma

international-pharma.com
1
115
AstraZeneca’s Tagrisso delivers positive results The company’s phase 3 study showed trea... tinyurl.com/2pnuu9vu tinyurl.com/2pnuu9vu
86
AeroGo Current Edition To access thi... tinyurl.com/2jgazt8e tinyurl.com/2jgazt8e
55
Pharmalex Current Edition To access thi... tinyurl.com/2flox7hu tinyurl.com/2flox7hu
50
It’s All About Stem Cells Current Edition It... tinyurl.com/2fvhmeb4 tinyurl.com/2fvhmeb4
28
DDL 2023 The Drug Delivery to the Lungs Conferen... tinyurl.com/2pcanap9 tinyurl.com/2pcanap9
18
Connect in Pharma launches partnerships for global health innovation Sciad Newswire / Connect in Pharma anno... tinyurl.com/2qmocfno tinyurl.com/2qmocfno
14
ELRIG UK Appoints Nick Clare to Board as Vendor Strategy Work Group Lead The European Laboratory Research & ... tinyurl.com/2oos9e96 tinyurl.com/2oos9e96
17
First patient dosed in pivotal CureVac flu vaccine study Modified influenza vaccine candidates h... tinyurl.com/2n3cqx2g tinyurl.com/2n3cqx2g
18
Positive opinion for Gilead’s Hepcludex The vital recommendation ensures market... tinyurl.com/2pybzjlj tinyurl.com/2pybzjlj
12
Endogena finalises enrolment for retinitis pigmentosa trial The treatment is a small molecule that ... tinyurl.com/2pznvl4o tinyurl.com/2pznvl4o

Endogena finalises enrolment for retinitis pigmentosa trial - International Pharmaceutical Industry

The treatment is a small molecule that activates endogenous retinal stem and progenitor cells

international-pharma.com
32
Ginkgo Bioworks, Boehringer Ingelheim partner on breakthrough therapies Ginkgo Bioworks, a Boston-based biotech... tinyurl.com/2qyj25sy tinyurl.com/2qyj25sy
40
Novavax to reduce workforce by 25% Maryland-based vaccine maker Novavax an... tinyurl.com/2l9yunyt tinyurl.com/2l9yunyt
24
Roche bets on Zion HER2 brain metastases prospect Roche has acquired the global rights to... tinyurl.com/2qv23ovt tinyurl.com/2qv23ovt
9
Explore The Latest Trends At PHARMAP 2023 Digital transformation, AI, Big Data an... tinyurl.com/2j7ly58l tinyurl.com/2j7ly58l
1
10
VYNE and Tay Therapeutics reach licence agreement The deal involves an oral BET inhibitor... tinyurl.com/2qmm5xcr tinyurl.com/2qmm5xcr
20
SporeGen and Destiny advance research collaboration The duo has partnered on developing a b... tinyurl.com/2hbkksrn tinyurl.com/2hbkksrn
1
NICE approves expanded use of Yescarta and Tecartus Kite’s two CAR T-Cell therapies involve... tinyurl.com/2jpuhsah tinyurl.com/2jpuhsah
29
Positive CHMP opinion for UCB’s bimekizumab Therapy concerns the treatment of adult... tinyurl.com/2namcol2 tinyurl.com/2namcol2
80
King's College London and Grünenthal join forces to ease pain Duo will collaborate to develop pluripo... tinyurl.com/2p5fradj tinyurl.com/2p5fradj
5
Load more